➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
AstraZeneca
Baxter
Johnson and Johnson
Boehringer Ingelheim

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Ferring B v. v. Allergan Inc. (S.D.N.Y. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Ferring B v. v. Allergan Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Ferring B v. v. Allergan Inc. (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 190 Memorandum & Opinion #39;s U.S. patent application 10/513,437 issued as U.S. Patent No. 7,560,429 (“the ’429 patent”). Lloyd…Fein’s U.S. patent application 11/744,615 issued as U.S. Patent No. 7,405,203 (“the ’203 patent”). Lloyd…Fein’s U.S. patent application 12/173,074 issued as U.S. Patent No. 7,579,321 (“the ’321 patent”). Lloyd…Fein’s U.S. patent application 10/706,100 issued as U.S. Patent No. 7,778,761 (“the ’761 patent”). Lloyd…Ferring’s U.S. patent application 12/487,116 issued as U.S. Patent No. 7,947,654 (“the ’654 patent”). Lloyd External link to document
0000-00-00 212 Memorandum & Opinion the inventorship of Patent Nos. 7,560,429 and 7,947,654 (collectively, the “Patents”). For the reasons …2009 Ferring’s U.S. patent application 10/513,437 issued as U.S. Patent No. 7,560,429. Cox Decl. EX. 13 …invention” patented in the '429 Patent and that Fein invented it, a comparison of the '429 Patent Claims…13 (the “'429 Patent”). On June 18, 2009, Ferring filed U.S. patent application 12/487,116 as a continuation…Filed 01/07/16 Page 8 of 30 patent application 12/487,116 issued as U.S. Patent No. 7,947,654. Cox Decl. External link to document
0000-00-00 241 Memorandum & Opinion joint inventor on two Ferring patents, United States Patents No. 7,560,429 and No. 7,947,654, based on … 30 September 2019 1:12-cv-02650 830 Patent None District Court, S.D. New External link to document
0000-00-00 270 Memorandum of Law in Support of Motion Pharmaceuticals Inc. ’429 patent U.S. Patent No. 7,560,429654 patent U.S. Patent No. 7,947,654 … Page CASES In re Rates - Viper Patent Litig., C.A. No. 09-4068-LTS, 2011 WL 856261…, and interest in Fein’s inventions—the three patents that Ferring sued on where Fein is a named inventor…inventor and all rights in the ’429 and ’654 patents that are the subjects of the counterclaims—to Allergan…correction of inventorship of the ’429 and ’654 patents to add Dr. Fein as a joint inventor. (See Dkt. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Baxter
Johnson and Johnson
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.